(Q71611889)
Statements
First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88 (English)
B Thürlimann
K Beretta
M Bacchi
M Castiglione-Gertsch
A Goldhirsch
W F Jungi
H J Senn
M Fey